Table 5 Cost per QALY gained for men with low risk localised prostate cancer
Age (years) | Life-time outcome | Watchful waiting | Active surveillance | Radical prostatectomy | Incremental analysis |
|---|---|---|---|---|---|
45 | Cost (NZ$) | $15,884 | $23,396 | $22,316 | RP vs WW: $6,432 per QALY; |
Effectiveness (QALYs) | 15.43 | 16.34 | 16.43 | AS was dominated by RP | |
50 | Cost (NZ$) | $14,192 | $21,115 | $20,991 | RP vs WW: $7,906 per QALY; |
Effectiveness (QALYs) | 14.49 | 15.24 | 15.35 | AS was dominated by RP | |
55 | Cost (NZ$) | $12,258 | $18,484 | $19,612 | RP vs WW: $10,358 per QALY; AS was extended dominated by WW and RP (AS vs WW: $10,377 per QALY; RP vs AS: $10,255 per QALY) |
Effectiveness (QALYs) | 13.37 | 13.97 | 14.08 | ||
60 | Cost (NZ$) | $10,113 | $15,461 | $18,254 | AS vs WW: $12,155 per QALY; |
Effectiveness (QALYs) | 12.08 | 12.52 | 12.65 | RP vs AS: $21,485 per QALY | |
65 | Cost (NZ$) | $7,843 | $11,998 | $16,972 | AS vs WW: $14,839 per QALY; |
Effectiveness (QALYs) | 10.62 | 10.90 | 11.05 | RP vs AS: $33,160 per QALY | |
70 | Cost (NZ$) | $5,560 | $7,976 | $15,821 | AS vs WW: $17,257 per QALY; |
Effectiveness (QALYs) | 9.03 | 9.17 | 9.35 | RP vs AS: $43,583 per QALY |